dockets: FDA-2008-P-0662
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | title | docket_type | last_modified | object_id | rin | dkabstract | category | subtype | keywords | program | short_title | effective_date | organization | attrs_raw | attr_source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2008-P-0662 | FDA | ANDA Suitability for Rifampkin Oral Suspension, 50 mg/5 mL and 10 mg/5 mL | Nonrulemaking | 2022-01-05T01:03:34Z | 0b0000648080800b | ["ANDA Suitability ", "Rifampkin Oral Suspension", "50 mg/5 mL ", "10 mg/5 mL", "CDER"] | CDER | {"displayProperties": [{"name": "generic", "label": "Docket Item Code", "tooltip": "An agency specific code that identifies the type of document that established the docket (regulatory action)."}, {"name": "program", "label": "Center", "tooltip": "The agency specific program associated with the docket (regulatory action); equivalents: Docket Item Code, Location."}], "keywords": ["ANDA Suitability ", "Rifampkin Oral Suspension", "50 mg/5 mL ", "10 mg/5 mL", "CDER"], "modifyDate": "2022-01-05T01:03:34Z", "dkAbstract": null, "agencyId": "FDA", "program": "CDER", "shortTitle": null, "subType2": null, "title": "ANDA Suitability for Rifampkin Oral Suspension, 50 mg/5 mL and 10 mg/5 mL", "generic": "P", "field1": null, "docketType": "Nonrulemaking", "petitionNbr": null, "rin": null, "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b0000648080800b"} | single_get |
Links from other tables
- 2 rows from docket_id in documents